Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (2)
P 2 (1)
P 3 (2)
P 4 (2)

Trial Status

Completed8
Unknown4
Recruiting3
Active Not Recruiting2
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07128550Phase 3RecruitingPrimary

A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide

NCT06903338Phase 3Active Not RecruitingPrimary

A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection

NCT07142811Phase 2Active Not RecruitingPrimary

A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection

NCT03743272Completed

Repeatability and Reproducibility of Multiparametric MRI

NCT06904820RecruitingPrimary

Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®

NCT04222803Suspended

VIRal Hepatitis and GAllstone Disease Study

NCT03933384Phase 4Recruiting

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

NCT06360484Completed

Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus

NCT04371276CompletedPrimary

Seroepidemiology of Viral Hepatitis in Hong Kong

NCT05207163Not ApplicableUnknownPrimary

Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers

NCT04304612Unknown

A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases

NCT04062253Completed

Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid

NCT04113915Unknown

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

NCT01766895Unknown

Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan

NCT01988753CompletedPrimary

Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases

NCT01082419Not ApplicableCompleted

Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity

NCT01476995Completed

Prognostic Indicators as Provided by the EPIC ClearView

NCT01195181Phase 4Completed

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Showing all 18 trials

Research Network

Activity Timeline